In the third blog of our PMCF Insights Series, PMCF Manager Chris Webb, highlights why it is imperative for manufacturers to provide clinical evidence to show their devices perform as expected over its entire lifetime, as specified within the Device Regulation (EU-MDR 2017/745).

Find out how we used a staged qualitative approach to help our client understand the landscape of digital solutions in GI endotherapy with a focus on AI, data management (clinical and non-clinical), workflow, and supply management.

When visiting a sensitive, emotive topic as a means to creating or refining a communications strategy, how can you optimize the true value of the voice of your customer? Join Purdie Pascoe’s expert presenters, Head of MedTech, Sabera Hyderally and Pharma Director, Hazel Haskayne, for this insightful live webinar on Wednesday 9th April to learn about the true value of the Delphi Method. 

Stephen Potts and Seb Newton recently attended the 2025 UK One-Day EPHMRA meeting in London. The focus of the event was ‘Storytelling in Market Research’ and how as market researchers, our mission is to ensure the insights we deliver tell a meaningful, powerful story to a diverse range of stakeholders. This summary delves into key themes and presentations from experts in the field.

With over 25 years of experience in the industry, Hazel Haskayne offers valuable insights into pharmaceutical market research. She explores the evolution of the industry, addresses key challenges and solutions in launching new pharma products, and highlights the crucial factors to consider when selecting an agency for your market research needs.

Post-market clinical follow-up (PMCF) surveys have become a significant topic in the industry, offering a cost-effective solution for PMCF data collection. However, their effective implementation can be challenging. In this article, the PMCF experts at Purdie Pascoe focus on high-quality, case/patient-specific PMCF surveys that provide Level 4 data.

There are over 300 million people living with a rare disease across the globe, and they need help. Purdie Pascoe is dedicated to partnering with life science companies to make timely, informed decisions, and help improve the lives of those affected by rare diseases worldwide.

We are delighted to be the platinum sponsor for the 6th Annual European Medical Device and Diagnostic Clinical Evidence Strategy Conference in Berlin. PMCF Managers Chris Webb and Alice Robertson will be attending and presenting at the conference.

Watch this complimentary webcast in which PMCF Manager from Purdie Pascoe, Chris Webb, presented with Dr. Ulrich Nitsche Global Director Clinical Centre of Excellence from TÜV SÜD and Dr. Nikhil A. Khadabadi from Eclevar MedTech. These leading experts unpack critical PMCF strategies, share real-world survey experiences, and offer insights on bridging data gaps to achieve regulatory success.

In the second blog of our PMCF Insights Series, Tonika Chester and Isabel Bradshaw explore off-label usage within medical devices, from collecting off-label data in post market clinical follow up, understanding and key considerations for off-label usages to the challenges in paediatric populations and rare diseases.

Purdie Pascoe is conducting an ongoing ctDNA Cancer Monitoring US Landscape syndicated study. The first two waves are available for purchase, with a third wave set to launch soon.

A leading medical device manufacturer required Post Market Clinical Follow-Up (PMCF) data for their Class III Peripherally Inserted Central Catheter (PICC). This clinical evidence was needed to comply with PMCF data collection under the MDR

Marianne Fillion provides insights about the Precision Medicine and Diagnostics market research function at Purdie Pascoe. She delves into technological advancements, the competitive oncology landscape and why market research is so important for development and implementation in this space.

In 2024, Stephen Potts, Director at Purdie Pascoe, was diagnosed with a giant brain aneurysm that required complex surgery and a long recovery journey. Thanks to the exceptional care from his surgeons, doctors, therapists and nurses, Stephen has made significant strides in his recovery and is now enthusiastically back at work.

We are thrilled to announce that Marcus Torr, PMCF/MDR Lead at Purdie Pascoe, has been selected for the MedTech Leading Voice (MLV) list for 2025. Marcus regularly shares his expertise at industry events and on LinkedIn. We are incredibly proud to see him featured in the prestigious MLV100 list. Don't miss his future insights by following him on LinkedIn.

At Purdie Pascoe, one of our core values is ‘Supportive.’ We are dedicated to helping local communities and charities, doing our part to assist those in need. Our charity initiative group works tirelessly throughout the year to identify the best ways to support a variety of charities and local communities.

We are delighted to be exhibiting and presenting a paper at the Pharma Market Research Conference (PMRC) from February 5-6 in New Jersey. Sabera Hyderally, Head of MedTech and Kristy Beede, Director, will be representing Purdie Pascoe at the event.

Find out how we provided our client with a clear and effective path forward to help launch their pre-filled syringes for subcutaneous immunoglobulin therapy, and how best to position themselves for widespread adoption.

In the first blog of our PMCF Insights Series, Hemant Mistry and Matthew Hanson explore different types of bias in medical device research, the measures being taken to address these issues, and how Purdie Pascoe's deep expertise helps eliminate bias in PMCF surveys.

Lindsey Cotterill provides her perspective about the importance of a robust operations and compliance function to ensure seamless execution of primary market research projects and PMCF surveys. She delves into key compliance regulations, strategies to ensure security and confidentiality of data and how each Purdie Pascoe employee is diligently trained about compliance issues and best practices.